Evaluation of the patients diagnosed as idiopathic intracranial hypertension with and without papilledema visual pathways by analysis of visual evoked potential

References

• Ball AK, Clarke CE. Idiopathic intracranial hypertension. Lancet Neurol. 2006;5(5):433–442.
   PubMed Web of Science ®Google Scholar
• Walker RW. Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure. J Neurol Neurosurg Psychiatry. 2001;71(1):1–5.
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
   PubMed Web of Science ®Google Scholar
• Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology. 1999;52(4):870–872.
   PubMed Web of Science ®Google Scholar
• Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990;10(6):331–335.
   PubMed Web of Science ®Google Scholar
• Giuseffi V, Wall M, Siegel PZ, et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991;41(2, Part 1):239–244.
   PubMed Web of Science ®Google Scholar
• Mathews MK, Sergott RC, Savino PJ. Pseudotumor cerebri. Curr Opin Ophthalmol. 2003;14(6):364–370.
   PubMedGoogle Scholar
• Binder DK, Horton JC, Lawton MT, et al. Idiopathic intracranial hypertension. Neurosurgery. 2004;54(3):538–551.
   PubMed Web of Science ®Google Scholar
• Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol. 2004;24(2):138–145.
   PubMed Web of Science ®Google Scholar
• Brazis PW. Pseudotumor cerebri. Curr Neurol Neurosci Rep. 2004;4(2):111–116.
   PubMedGoogle Scholar
• Wall M. Pseudotumor cerebri. Curr Opin Ophthalmol. 2003;14(6):364–370.
   PubMedGoogle Scholar
• Friedman DI. Pseudotumor cerebri presenting as headache. Expert Rev Neurother. 2008;8(3):397–407.
   PubMedGoogle Scholar
• Wall M. Idiopathic intracranial hypertension: mechanisms of visual loss and disease management. Semin Neurol. 2000;20(1):89–95.
   PubMed Web of Science ®Google Scholar
• Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71(6):693–701.
   PubMed Web of Science ®Google Scholar
• Bonavita V, De Simone R. The lesson of chronic migraine. Neurol Sci. 2015;36(Suppl 1):101–107.
   PubMed Web of Science ®Google Scholar
• Mallery RM, Friedman DI, Liu GT. Headache and the pseudotumor cerebri syndrome. Curr Pain Headache Rep. 2014;18(9):446.
   PubMed Web of Science ®Google Scholar
• Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain. 1974;97(1):301–312.
   PubMed Web of Science ®Google Scholar
• Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology. 1996;46(5):1226–1230.
   PubMed Web of Science ®Google Scholar
• Marzoli SB, Ciasca P, Curone M, et al. Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis. Neurol Sci. 2013;34(S1):143–145.
   PubMed Web of Science ®Google Scholar
• Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49(2):185–193.
   PubMed Web of Science ®Google Scholar
• Verplanck M, Kaufman DI, Parsons T, et al. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri. Neurology. 1988;38(11):1789–1792.
   PubMed Web of Science ®Google Scholar
• Falsini B, Tamburrelli C, Porciatti V, et al. Pattern electroretinograms and visual evoked potentials in idiopathic intracranial hypertension. Ophthalmologica. 1992;205(4):194–203.
   PubMed Web of Science ®Google Scholar
• Bobak P, Friedman R, Brigell M, et al. Visual evoked potentials to multiple temporal frequencies. Use in the differential diagnosis of optic neuropathy. Arch Ophthalmol. 1988;106(7):936–940.
   PubMedGoogle Scholar
• Rizzo PA, Pierelli F, Pozzessere G, et al. Pattern visual evoked potential in pseudotumor cerebri. A longitudinal study. Acta Neurol Belg. 1984;84(2):57–63.
   PubMed Web of Science ®Google Scholar
• Sorensen PS, Trojaborg W, Gjerris F, et al. Visual evoked potentials in pseudotumor cerebri. Arch Neurol. 1985;42(2):150–153.
   PubMedGoogle Scholar
• Cox TA, Thompson HS, Hayreh SS, Snyder JE. Visual evoked potential and pupillary signs. A comparison in optic nerve disease. Arch Ophthalmol. 1982;100(10):1603–1607.
   PubMedGoogle Scholar
• Parisi V, Miglior S, Manni G, et al. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. Ophthalmology. 2006;113(2):216–228.
   PubMed Web of Science ®Google Scholar
• Tormene AP, Doro D, Mantovani E, et al. Electrophysiological findings in anterior ischemic optic neuropathy. Metab Pediatr Syst Ophthalmol (1985). 1989;12(1–3):76–79.
   PubMedGoogle Scholar
• Kesler A, Vakhapova V, Korczyn AD, et al. Visual evoked potentials in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2009;111(5):433–436.
   PubMed Web of Science ®Google Scholar
• Hartmann CJ, Klistorner AI, Brandt AU, et al. Axonal damage in papilledema linked to idiopathic intracranial hypertension as revealed by multifocal visual evoked potentials. Clin Neurophysiol. 2015;126(10):2040–2041.
   PubMed Web of Science ®Google Scholar
• Mackinnon SE. Pathophysiology of nerve compression. Hand Clin. 2002;18(2):231–241.
   PubMed Web of Science ®Google Scholar
• Nordic Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641–1651.
   PubMed Web of Science ®Google Scholar